← Back to Search

PrEP@Home System for HIV/AIDS (PrEP@Home Trial)

Q: Could I possibly be approved to take part in this experiment?

<p>This research is open to <a href="https://www.withpower.com/clinical-trials/hiv">HIV</a>-positive individuals between 18-49 years old. At present, the study needs around 396 more participants.</p>

N/A

Waitlist Available

Led By Aaron Siegler, PhD

Research Sponsored by Emory University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up month 12

Awards & highlights

PrEP@Home Trial Summary

This trial is testing a home care system for HIV PrEP against the standard of care to see if it is just as effective.

Eligible Conditions

HIV/AIDS

PrEP@Home Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ month 12

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~month 12

This trial's timeline: 3 weeks for screening, Varies for treatment, and month 12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Diﬀerence in emtricitabine (FTC) levels between intervention and control arms at 12-month follow-up

Secondary outcome measures

Diﬀerence in emtricitabine (FTC) levels between intervention and control arms at 6-month follow-up

Retention in PrEP care

PrEP@Home Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: PrEP@Home SystemExperimental Treatment1 Intervention

The experimental group will be assigned to the remote care system for one year of follow-up PrEP care to include home test kits and behavioral surveillance, and telemedicine visits as needed.

Group II: Standard of CareActive Control1 Intervention

The comparator group will receive active linkage to a local PrEP provider for clinic-based PrEP follow-up. Participants in this study arm will be seen quarterly by a health care provider, per standard of care when taking PrEP.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

PrEP@Home System

2019

N/A

~320

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Emory UniversityLead Sponsor

1,640 Previous Clinical Trials

2,560,378 Total Patients Enrolled

National Institute of Mental Health (NIMH)NIH

2,786 Previous Clinical Trials

2,689,449 Total Patients Enrolled

Aaron Siegler, PhDPrincipal Investigator - Emory University

Emory University

1 Previous Clinical Trials

217 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Could you tell me if this trial is accepting patients who are under the age of 40?

"This particular clinical trial only allows enrolment from patients aged 18 to 49. However, there are 114 other trials for patients under 18 and 392 for patients over 65."

Answered by AI

Could I possibly be approved to take part in this experiment?

"This research is open to HIV-positive individuals between 18-49 years old. At present, the study needs around 396 more participants."

Answered by AI

At how many hospitals or research institutions is this research project underway?

"There are 5 sites currently running this trial, including the Open Arms Health Care Center in Jackson, MetroHealth in Cleveland, and The Fenway Institute in Boston, as well as 5 other locations."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Pre-exposure Prophylaxis (PrEP) at Home

Aaron Siegler 2019. "Pre-exposure Prophylaxis (PrEP) at Home". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03569813.